58168-20-0 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 5-amino-4-cyano-3-(2-ethoxy-2-oxoethyl)thiophene-2-carboxylate is used as a pharmaceutical candidate for its potential therapeutic applications. Its structural features, including the ethyl ester, amino, and cyano groups, may enable it to interact with biological systems, making it a promising compound for the development of new drugs.
Ethyl 5-amino-4-cyano-3-(2-ethoxy-2-oxoethyl)thiophene-2-carboxylate is used as a precursor in the synthesis of other pharmaceutical compounds. Its unique structure and reactivity may allow for the creation of novel drug molecules with improved efficacy and selectivity.
Used in Medicinal Chemistry Research:
Ethyl 5-amino-4-cyano-3-(2-ethoxy-2-oxoethyl)thiophene-2-carboxylate is used as a research tool in medicinal chemistry. Its synthesis and properties make it a valuable compound for studying the interactions between small molecules and biological systems, potentially leading to the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 58168-20-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,1,6 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 58168-20:
(7*5)+(6*8)+(5*1)+(4*6)+(3*8)+(2*2)+(1*0)=140
140 % 10 = 0
So 58168-20-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H14N2O4S/c1-3-17-9(15)5-7-8(6-13)11(14)19-10(7)12(16)18-4-2/h3-5,14H2,1-2H3
58168-20-0Relevant academic research and scientific papers
Hongtao, Wei,Jin, Cai,Min, Sun,Min, Ji
, p. 236 - 238 (2007)
Thieno[2,3-b]pyrroles can be synthesized through three steps: Gewald synthesis, alkylation, and Thorpe-Ziegler cyclization. Diethyl 3,6-bis ((ethoxycarbonyl)methyl)-4-amino-6H-thieno-[2,3-b]pyrrole-2,5-dicarboxylate (13) has been obtained by one-pot method in DMF in good yield and high quality.
PROCESS FOR THE PREPARATION OF STRONTIUM RANELATE, INTERMEDIATE OR HYDRATES THEREOF
-
Page/Page column 6, (2013/08/15)
The present invention relates to an improved process for the synthesis of strontium ranelate compound of formula I or its hydrates thereof. More particularly, the present invention relates to an economically viable and industrially feasible process for the preparation of strontium ranelate, intermediate or its hydrates thereof.
SUBSTANTIALLY PURE STRONTIUM RANELATE
-
Page/Page column 19, (2011/10/31)
Provided herein is an improved, commercially viable and industrially advantageous process for the preparation of strontium ranelate, and its intermediates, in high yield and purity. Provided further herein is a highly pure strontium ranelate substantially free of impurities, and pharmaceutical compositions comprising highly pure strontium ranelate substantially free of impurities.
